Skip to main content

Table 1 Baseline characteristics of the study patients and treatments for IPF before the first admission for pneumothorax

From: Pneumothorax in patients with idiopathic pulmonary fibrosis: a real-world experience

Characteristics

Nā€‰=ā€‰36

Age, year

75.5ā€‰Ā±ā€‰5.4

Gender

Ā Male/female

29/7

Body mass indexa, kg/m2

18.5ā€‰Ā±ā€‰4.1

Preadmission of PFT

Ā FVCb, L

1.6ā€‰Ā±ā€‰0.6

Ā FVCb, % predicted

55.8ā€‰Ā±ā€‰16.5

Ā FEV1b, L

1.5ā€‰Ā±ā€‰0.5

Ā FEV1b, % predicted

66.2ā€‰Ā±ā€‰18.4

Ā FEV1/FVCb, %

91.7ā€‰Ā±ā€‰10.6

Ā DLcoc, mL/min/mmHg

8.3ā€‰Ā±ā€‰2.2

Ā DLcoc, % predicted

62.4ā€‰Ā±ā€‰14.9

Smoking status

Ā Current/former/never

1/25/10

Treatment for IPF at baseline

Ā Pirfenidone

4

Ā Nintedanib

3

Ā Corticosteroid

7

Ā Cyclosporine

4

Ā None

22

Long-term oxygen therapy

Ā Yes/no

9/27

  1. Values are shown as actual numbers or meansā€‰Ā±ā€‰standard deviation
  2. Nā€‰=ā€‰36 (aNā€‰=ā€‰35, bNā€‰=ā€‰27, cNā€‰=ā€‰12)
  3. DLco, diffusing capacity for carbon monoxide; FEV1, forced expiratory volume in 1Ā s; FVC, forced vital capacity; IPF, idiopathic pulmonary fibrosis; PFT, pulmonary function tests